<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>826</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>12496160</PubmedId>
            <Abstract>Surface layer proteins (SLPs) are essential for induction of abortion by Campylobacter fetus subsp. fetus in experimentally challenged ewes. These proteins are encoded by multiple sap genes and vary in size and antigenicity. The role of SLP antigenic variation during experimental ovine infection was investigated. Following subcutaneous challenge, the SLPs were highly antigenic, and antibodies were detected in serum, milk, bile, and urine. Fecal anti-SLP antibodies were detected only in animals challenged orally. Ewes challenged with wild-type strain 23D with variable SLPs developed detectable circulating anti-SLP immunoglobulin G (IgG) antibodies by 2 weeks postchallenge. In contrast, ewes challenged with mutants of 23D that had fixed expression of a single SLP developed antibodies within 1 week postchallenge, suggesting that antigenic variation in SLPs may delay the host antibody response. Although not statistically significant, the data from challenge experiments in which vaccinated ewes were used suggested that SLP-expressing vaccines could protect animals from abortion and that this effect was independent of the SLP expressed, indicating involvement of conserved epitopes in the SLP. The conserved 184-amino-acid N-terminal region of the SLP, identified from previously published sequences, was epitope mapped with rabbit anti-SLP antisera by using overlapping synthetic 20-mer peptides. Two putative epitopes were identified at amino acids 81 to 110 and 141 to 160. Amino acids 81 to 100 also bound serum IgG antibodies from experimentally challenged sheep. Conserved antigenic regions of the SLP that induce protective immune responses may enable development of synthetic vaccine candidates for C. fetus subsp. fetus-associated ovine abortion.</Abstract>
            <ArticleYear>2003</ArticleYear>
            <ArticlePages>147-54</ArticlePages>
            <ArticleTitle>Role of S-layer protein antigenic diversity in the immune responses of sheep experimentally challenged with Campylobacter fetus subsp. fetus.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Grogono-Thomas</LastName>
                    <ForeName>R</ForeName>
                </Author>
                <Author>
                    <LastName>Blaser</LastName>
                    <ForeName>M J</ForeName>
                </Author>
                <Author>
                    <LastName>Ahmadi</LastName>
                    <ForeName>M</ForeName>
                </Author>
                <Author>
                    <LastName>Newell</LastName>
                    <ForeName>D G</ForeName>
                </Author>
            </Authors>
            <Affiliations>Royal Veterinary College, Potters Bar, Herts, United Kingdom.</Affiliations>
            <ArticleChemicalList>Antibodies, Bacterial;Antigens, Bacterial;Bacterial Outer Membrane Proteins;Bacterial Proteins;Bacterial Vaccines;Membrane Glycoproteins;S-layer proteins</ArticleChemicalList>
            <ArticleMeshHeadingsList>Abortion, Veterinary(immunology; prevention &amp; control); Animals; Antibodies, Bacterial(analysis; blood); Antigenic Variation; Antigens, Bacterial(immunology); Bacterial Outer Membrane Proteins(genetics; immunology); Bacterial Proteins; Bacterial Vaccines(administration &amp; dosage; immunology); Campylobacter Infections(immunology; prevention &amp; control; veterinary); Campylobacter fetus(immunology); Cattle; Epitope Mapping; Female; Immunization; Membrane Glycoproteins; Pregnancy; Rabbits; Sheep; Sheep Diseases(immunology; microbiology; prevention &amp; control)</ArticleMeshHeadingsList>
            <Journal>
                <Volume>71</Volume>
                <Issue>1</Issue>
                <Title>Infection and immunity</Title>
                <Issn>0019-9567</Issn>
                <MedlineTa>Infect Immun</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>1</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>MLNKTDVSMLYITIMGMASE</LinearSequence>
                        <StartingPosition>1</StartingPosition>
                        <EndingPosition>20</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAR21088.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>32019</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 6, Pubmed entry.</LocationOfData>
                <EpitopeId>42019</EpitopeId>
                <ReferenceStartingPosition>1</ReferenceStartingPosition>
                <ReferenceEndingPosition>20</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This epitope corresponds to the 184aa N-ter region, which is conserved in all SLPs described to date. Also known as Surface array protein (SAP), member of a  family of proteins in the bacteria surface and related to its virulence.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <BCellId>8943</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9940</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>32019</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>2 injections of 10&lt;sup&gt;8&lt;/sup&gt; CFU at 6 wk intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <AssayComments>No significant differences in reactivity to this peptide between pooled pre- and post-challenge sera is seen.  Peptides were covalently linked to the ELISA plated via EDC / NHS immobilization chemistry.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>1</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MLNKTDVSMLYITIMGMASE</LinearSequence>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>20</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAR21088.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>32019</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 6</LocationOfData>
                        <BCellId>8940</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAR21088.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>32019</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Surface Layer Protein (SLP)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 immunizations, 1st in CFA then in IFA at 4 wk intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>2</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>No significant differences in reactivity to this peptide between each immune sera and pooled preimmune sera is seen.  Peptides were covalently linked to the ELISA plated via EDC / NHS immobilization chemistry.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>1</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>MLNKTDVSMLYITIMGMASE</LinearSequence>
                                        <StartingPosition>1</StartingPosition>
                                        <EndingPosition>20</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAR21088.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>32019</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>2</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>YITIMGMASEGDGNKYWLDY</LinearSequence>
                        <StartingPosition>11</StartingPosition>
                        <EndingPosition>30</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAR21088.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>32019</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 6, Pubmed entry.</LocationOfData>
                <EpitopeId>74391</EpitopeId>
                <ReferenceStartingPosition>11</ReferenceStartingPosition>
                <ReferenceEndingPosition>30</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This epitope corresponds to the 184aa N-ter region, which is conserved in all SLPs described to date. Also known as Surface array protein (SAP), member of a  family of proteins in the bacteria surface and related to its virulence.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 6</LocationOfData>
                        <BCellId>8949</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAR21088.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>32019</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Surface Layer Protein (SLP)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 immunizations, 1st in CFA then in IFA at 4 wk intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>2</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>No significant differences in reactivity to this peptide between each immune sera and pooled preimmune sera is seen.  Peptides were covalently linked to the ELISA plated via EDC / NHS immobilization chemistry.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>2</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YITIMGMASEGDGNKYWLDY</LinearSequence>
                                        <StartingPosition>11</StartingPosition>
                                        <EndingPosition>30</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAR21088.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>32019</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <BCellId>8950</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9940</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>32019</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>2 injections of 10&lt;sup&gt;8&lt;/sup&gt; CFU at 6 wk intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <AssayComments>No significant differences in reactivity to this peptide between pooled pre- and post-challenge sera is seen.  Peptides were covalently linked to the ELISA plated via EDC / NHS immobilization chemistry.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>2</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>YITIMGMASEGDGNKYWLDY</LinearSequence>
                                        <StartingPosition>11</StartingPosition>
                                        <EndingPosition>30</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAR21088.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>32019</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>3</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GDGNKYWLDYANNNTLGVSS</LinearSequence>
                        <StartingPosition>21</StartingPosition>
                        <EndingPosition>40</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAO64210.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>32019</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 6, Pubmed entry.</LocationOfData>
                <EpitopeId>18989</EpitopeId>
                <ReferenceStartingPosition>21</ReferenceStartingPosition>
                <ReferenceEndingPosition>40</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This epitope corresponds to the 184aa N-ter region, which is conserved in all SLPs described to date. Also known as Surface array protein (SAP), member of a  family of proteins in the bacteria surface and related to its virulence.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 6</LocationOfData>
                        <BCellId>8951</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAO64210.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>32019</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Surface Layer Protein (SLP)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 immunizations, 1st in CFA then in IFA at 4 wk intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>2</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>No significant differences in reactivity to this peptide between each immune sera and pooled preimmune sera is seen.  Peptides were covalently linked to the ELISA plated via EDC / NHS immobilization chemistry.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>3</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GDGNKYWLDYANNNTLGVSS</LinearSequence>
                                        <StartingPosition>21</StartingPosition>
                                        <EndingPosition>40</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAO64210.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>32019</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <BCellId>8952</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9940</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>32019</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>2 injections of 10&lt;sup&gt;8&lt;/sup&gt; CFU at 6 wk intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <AssayComments>No significant differences in reactivity to this peptide between pooled pre- and post-challenge sera is seen.  Peptides were covalently linked to the ELISA plated via EDC / NHS immobilization chemistry.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>3</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GDGNKYWLDYANNNTLGVSS</LinearSequence>
                                        <StartingPosition>21</StartingPosition>
                                        <EndingPosition>40</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAO64210.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>32019</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>4</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ANNNTLGVSSLANIMLDSPG</LinearSequence>
                        <StartingPosition>31</StartingPosition>
                        <EndingPosition>50</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAO64210.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>32019</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 6, Pubmed entry.</LocationOfData>
                <EpitopeId>3360</EpitopeId>
                <ReferenceStartingPosition>31</ReferenceStartingPosition>
                <ReferenceEndingPosition>50</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This epitope corresponds to the 184aa N-ter region, which is conserved in all SLPs described to date. Also known as Surface array protein (SAP), member of a  family of proteins in the bacteria surface and related to its virulence.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 6</LocationOfData>
                        <BCellId>8953</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAO64210.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>32019</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Surface Layer Protein (SLP)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 immunizations, 1st in CFA then in IFA at 4 wk intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>2</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>No significant differences in reactivity to this peptide between each immune sera and pooled preimmune sera is seen.  Peptides were covalently linked to the ELISA plated via EDC / NHS immobilization chemistry.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>4</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ANNNTLGVSSLANIMLDSPG</LinearSequence>
                                        <StartingPosition>31</StartingPosition>
                                        <EndingPosition>50</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAO64210.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>32019</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <BCellId>8954</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9940</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>32019</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>2 injections of 10&lt;sup&gt;8&lt;/sup&gt; CFU at 6 wk intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <AssayComments>No significant differences in reactivity to this peptide between pooled pre- and post-challenge sera is seen.  Peptides were covalently linked to the ELISA plated via EDC / NHS immobilization chemistry.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>4</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ANNNTLGVSSLANIMLDSPG</LinearSequence>
                                        <StartingPosition>31</StartingPosition>
                                        <EndingPosition>50</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAO64210.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>32019</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>5</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LANIMLDSPGAAKFFGDSLL</LinearSequence>
                        <StartingPosition>41</StartingPosition>
                        <EndingPosition>60</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAO64231.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>32019</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 6, Pubmed entry.</LocationOfData>
                <EpitopeId>34885</EpitopeId>
                <ReferenceStartingPosition>41</ReferenceStartingPosition>
                <ReferenceEndingPosition>50</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This epitope corresponds to the 184aa N-ter region, which is conserved in all SLPs described to date. Also known as Surface array protein (SAP), member of a  family of proteins in the bacteria surface and related to its virulence.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <BCellId>8956</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9940</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>32019</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>2 injections of 10&lt;sup&gt;8&lt;/sup&gt; CFU at 6 wk intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <AssayComments>No significant differences in reactivity to this peptide between pooled pre- and post-challenge sera is seen.  Peptides were covalently linked to the ELISA plated via EDC / NHS immobilization chemistry.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>5</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LANIMLDSPGAAKFFGDSLL</LinearSequence>
                                        <StartingPosition>41</StartingPosition>
                                        <EndingPosition>60</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAO64231.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>32019</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 6</LocationOfData>
                        <BCellId>8955</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAO64231.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>32019</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Surface Layer Protein (SLP)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 immunizations, 1st in CFA then in IFA at 4 wk intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>2</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>No significant differences in reactivity to this peptide between each immune sera and pooled preimmune sera is seen.  Peptides were covalently linked to the ELISA plated via EDC / NHS immobilization chemistry.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>5</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LANIMLDSPGAAKFFGDSLL</LinearSequence>
                                        <StartingPosition>41</StartingPosition>
                                        <EndingPosition>60</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAO64231.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>32019</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>6</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>AAKFFGDSLLAGNEKDFVTK</LinearSequence>
                        <StartingPosition>51</StartingPosition>
                        <EndingPosition>70</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAR21088.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>32019</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 6, Pubmed entry.</LocationOfData>
                <EpitopeId>245</EpitopeId>
                <ReferenceStartingPosition>51</ReferenceStartingPosition>
                <ReferenceEndingPosition>70</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This epitope corresponds to the 184aa N-ter region, which is conserved in all SLPs described to date. Also known as Surface array protein (SAP), member of a  family of proteins in the bacteria surface and related to its virulence.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <BCellId>8958</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9940</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>32019</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>2 injections of 10&lt;sup&gt;8&lt;/sup&gt; CFU at 6 wk intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <AssayComments>No significant differences in reactivity to this peptide between pooled pre- and post-challenge sera is seen.  Peptides were covalently linked to the ELISA plated via EDC / NHS immobilization chemistry.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>6</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AAKFFGDSLLAGNEKDFVTK</LinearSequence>
                                        <StartingPosition>51</StartingPosition>
                                        <EndingPosition>70</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAR21088.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>32019</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 6</LocationOfData>
                        <BCellId>8957</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAR21088.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>32019</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Surface Layer Protein (SLP)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 immunizations, 1st in CFA then in IFA at 4 wk intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>2</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>No significant differences in reactivity to this peptide between each immune sera and pooled preimmune sera is seen.  Peptides were covalently linked to the ELISA plated via EDC / NHS immobilization chemistry.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>6</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AAKFFGDSLLAGNEKDFVTK</LinearSequence>
                                        <StartingPosition>51</StartingPosition>
                                        <EndingPosition>70</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAR21088.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>32019</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>7</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>AGNEKDFVTKIYSIALGNTS</LinearSequence>
                        <StartingPosition>61</StartingPosition>
                        <EndingPosition>80</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAR21088.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>32019</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 6, Pubmed entry.</LocationOfData>
                <EpitopeId>1618</EpitopeId>
                <ReferenceStartingPosition>61</ReferenceStartingPosition>
                <ReferenceEndingPosition>80</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This epitope corresponds to the 184aa N-ter region, which is conserved in all SLPs described to date. Also known as Surface array protein (SAP), member of a  family of proteins in the bacteria surface and related to its virulence.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <BCellId>8962</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9940</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>32019</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>2 injections of 10&lt;sup&gt;8&lt;/sup&gt; CFU at 6 wk intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <AssayComments>No significant differences in reactivity to this peptide between pooled pre- and post-challenge sera is seen.  Peptides were covalently linked to the ELISA plated via EDC / NHS immobilization chemistry.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>7</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AGNEKDFVTKIYSIALGNTS</LinearSequence>
                                        <StartingPosition>61</StartingPosition>
                                        <EndingPosition>80</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAR21088.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>32019</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 6</LocationOfData>
                        <BCellId>8961</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAR21088.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>32019</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Surface Layer Protein (SLP)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 immunizations, 1st in CFA then in IFA at 4 wk intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>2</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>No significant differences in reactivity to this peptide between each immune sera and pooled preimmune sera is seen.  Peptides were covalently linked to the ELISA plated via EDC / NHS immobilization chemistry.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>7</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AGNEKDFVTKIYSIALGNTS</LinearSequence>
                                        <StartingPosition>61</StartingPosition>
                                        <EndingPosition>80</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAR21088.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>32019</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>8</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>IYSIALGNTSDVDGINYWTK</LinearSequence>
                        <StartingPosition>71</StartingPosition>
                        <EndingPosition>90</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAR21088.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>32019</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 6, Pubmed entry.</LocationOfData>
                <EpitopeId>29680</EpitopeId>
                <ReferenceStartingPosition>71</ReferenceStartingPosition>
                <ReferenceEndingPosition>90</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This epitope corresponds to the 184aa N-ter region, which is conserved in all SLPs described to date. Also known as Surface array protein (SAP), member of a  family of proteins in the bacteria surface and related to its virulence.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 6</LocationOfData>
                        <BCellId>8963</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAR21088.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>32019</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Surface Layer Protein (SLP)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 immunizations, 1st in CFA then in IFA at 4 wk intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>2</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>No significant differences in reactivity to this peptide between each immune sera and pooled preimmune sera is seen.  Peptides were covalently linked to the ELISA plated via EDC / NHS immobilization chemistry.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>8</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IYSIALGNTSDVDGINYWTK</LinearSequence>
                                        <StartingPosition>71</StartingPosition>
                                        <EndingPosition>90</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAR21088.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>32019</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <BCellId>8964</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9940</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>32019</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>2 injections of 10&lt;sup&gt;8&lt;/sup&gt; CFU at 6 wk intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <AssayComments>No significant differences in reactivity to this peptide between pooled pre- and post-challenge sera is seen.  Peptides were covalently linked to the ELISA plated via EDC / NHS immobilization chemistry.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>8</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>IYSIALGNTSDVDGINYWTK</LinearSequence>
                                        <StartingPosition>71</StartingPosition>
                                        <EndingPosition>90</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAR21088.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>32019</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>9</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>DVDGINYWTKAITGGGEFTD</LinearSequence>
                        <StartingPosition>81</StartingPosition>
                        <EndingPosition>100</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAR21088.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>32019</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 6, Pubmed entry.</LocationOfData>
                <EpitopeId>10551</EpitopeId>
                <ReferenceStartingPosition>81</ReferenceStartingPosition>
                <ReferenceEndingPosition>100</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This epitope corresponds to the 184aa N-terminal region, which is conserved in all SLPs described to date. This peptide contains an epitope for rabbit and sheep humoral immune response. In rabbits,  adjacent overlapping peptide 10 (aa 91-110) is recognized strongly, suggesting epitope is in sequence aa 91-100, but sheep did not significantly recognize peptide 10. Also known as Surface array protein (SAP), member of a  family of proteins in the bacteria surface and related to its virulence.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 6</LocationOfData>
                        <BCellId>8965</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAR21088.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>32019</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Surface Layer Protein (SLP)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 immunizations, 1st in CFA then in IFA at 4 wk intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>2</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>2</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>Significant differences in reactivity to this peptide among both immune sera and pooled preimmune sera is seen.  Peptides were covalently linked to the ELISA plated via EDC / NHS immobilization chemistry.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>9</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>DVDGINYWTKAITGGGEFTD</LinearSequence>
                                        <StartingPosition>81</StartingPosition>
                                        <EndingPosition>100</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAR21088.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>32019</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <BCellId>8966</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9940</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>32019</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>2 injections of 10&lt;sup&gt;8&lt;/sup&gt; CFU at 6 wk intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <AssayComments>Significant differences in reactivity to this peptide between pooled pre- and post-challenge sera is seen.  Peptides were covalently linked to the ELISA plated via EDC / NHS immobilization chemistry.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>9</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>DVDGINYWTKAITGGGEFTD</LinearSequence>
                                        <StartingPosition>81</StartingPosition>
                                        <EndingPosition>100</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAR21088.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>32019</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>10</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>AITGGGEFTDSKGNVISVAS</LinearSequence>
                        <StartingPosition>91</StartingPosition>
                        <EndingPosition>110</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAR21088.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>32019</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 6, Pubmed entry.</LocationOfData>
                <EpitopeId>2104</EpitopeId>
                <ReferenceStartingPosition>91</ReferenceStartingPosition>
                <ReferenceEndingPosition>110</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This epitope corresponds to the 184aa N-ter region, which is conserved in all SLPs described to date. This peptide contains an epitope for rabbit humoral immune response. Adjacent overlapping peptide 9 (aa 81-100) is also recognized, suggesting epitope is in sequence aa 91-100, but in sheep only peptide 9 is recognized. Also known as Surface array protein (SAP), member of a  family of proteins in the bacteria surface and related to its virulence.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <BCellId>8968</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9940</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>32019</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>2 injections of 10&lt;sup&gt;8&lt;/sup&gt; CFU at 6 wk intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <AssayComments>No significant differences in reactivity to this peptide between pooled pre- and post-challenge sera is seen.  Peptides were covalently linked to the ELISA plated via EDC / NHS immobilization chemistry.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>10</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AITGGGEFTDSKGNVISVAS</LinearSequence>
                                        <StartingPosition>91</StartingPosition>
                                        <EndingPosition>110</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAR21088.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>32019</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 6</LocationOfData>
                        <BCellId>8967</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAR21088.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>32019</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Surface Layer Protein (SLP)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 immunizations, 1st in CFA then in IFA at 4 wk intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>2</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>2</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>Significant differences in reactivity to this peptide among both immune sera and pooled preimmune sera is seen.  Peptides were covalently linked to the ELISA plated via EDC / NHS immobilization chemistry.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>10</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AITGGGEFTDSKGNVISVAS</LinearSequence>
                                        <StartingPosition>91</StartingPosition>
                                        <EndingPosition>110</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAR21088.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>32019</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>11</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>SKGNVISVASLSKGDLIGAM</LinearSequence>
                        <StartingPosition>101</StartingPosition>
                        <EndingPosition>120</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAR21088.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>32019</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 6, Pubmed entry.</LocationOfData>
                <EpitopeId>58838</EpitopeId>
                <ReferenceStartingPosition>101</ReferenceStartingPosition>
                <ReferenceEndingPosition>120</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This epitope corresponds to the 184aa N-ter region, which is conserved in all SLPs described to date. Also known as Surface array protein (SAP), member of a  family of proteins in the bacteria surface and related to its virulence.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <BCellId>8970</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9940</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>32019</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>2 injections of 10&lt;sup&gt;8&lt;/sup&gt; CFU at 6 wk intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <AssayComments>No significant differences in reactivity to this peptide between pooled pre- and post-challenge sera is seen.  Peptides were covalently linked to the ELISA plated via EDC / NHS immobilization chemistry.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>11</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SKGNVISVASLSKGDLIGAM</LinearSequence>
                                        <StartingPosition>101</StartingPosition>
                                        <EndingPosition>120</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAR21088.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>32019</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 6</LocationOfData>
                        <BCellId>8969</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAR21088.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>32019</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Surface Layer Protein (SLP)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 immunizations, 1st in CFA then in IFA at 4 wk intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>2</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>No significant differences in reactivity to this peptide between each immune sera and pooled preimmune sera is seen.  Peptides were covalently linked to the ELISA plated via EDC / NHS immobilization chemistry.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>11</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>SKGNVISVASLSKGDLIGAM</LinearSequence>
                                        <StartingPosition>101</StartingPosition>
                                        <EndingPosition>120</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAR21088.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>32019</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>12</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LSKGDLIGAMINSMVNGGSA</LinearSequence>
                        <StartingPosition>111</StartingPosition>
                        <EndingPosition>130</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAR21088.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>32019</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 6, Pubmed entry.</LocationOfData>
                <EpitopeId>39455</EpitopeId>
                <ReferenceStartingPosition>111</ReferenceStartingPosition>
                <ReferenceEndingPosition>130</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This epitope corresponds to the 184aa N-ter region, which is conserved in all SLPs described to date. Also known as Surface array protein (SAP), member of a  family of proteins in the bacteria surface and related to its virulence.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <BCellId>8972</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9940</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>32019</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>2 injections of 10&lt;sup&gt;8&lt;/sup&gt; CFU at 6 wk intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <AssayComments>No significant differences in reactivity to this peptide between pooled pre- and post-challenge sera is seen.  Peptides were covalently linked to the ELISA plated via EDC / NHS immobilization chemistry.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>12</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LSKGDLIGAMINSMVNGGSA</LinearSequence>
                                        <StartingPosition>111</StartingPosition>
                                        <EndingPosition>130</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAR21088.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>32019</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 6</LocationOfData>
                        <BCellId>8971</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAR21088.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>32019</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Surface Layer Protein (SLP)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 immunizations, 1st in CFA then in IFA at 4 wk intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>2</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>No significant differences in reactivity to this peptide between each immune sera and pooled preimmune sera is seen.  Peptides were covalently linked to the ELISA plated via EDC / NHS immobilization chemistry.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>12</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LSKGDLIGAMINSMVNGGSA</LinearSequence>
                                        <StartingPosition>111</StartingPosition>
                                        <EndingPosition>130</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAR21088.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>32019</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>13</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>INSMVNGGSAESKAIFEAKA</LinearSequence>
                        <StartingPosition>121</StartingPosition>
                        <EndingPosition>140</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAR21088.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>32019</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 6, Pubmed entry.</LocationOfData>
                <EpitopeId>27736</EpitopeId>
                <ReferenceStartingPosition>121</ReferenceStartingPosition>
                <ReferenceEndingPosition>140</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This epitope corresponds to the 184aa N-ter region, which is conserved in all SLPs described to date. Also known as Surface array protein (SAP), member of a  family of proteins in the bacteria surface and related to its virulence.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 6</LocationOfData>
                        <BCellId>8973</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAR21088.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>32019</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Surface Layer Protein (SLP)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 immunizations, 1st in CFA then in IFA at 4 wk intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>2</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>No significant differences in reactivity to this peptide between each immune sera and pooled preimmune sera is seen.  Peptides were covalently linked to the ELISA plated via EDC / NHS immobilization chemistry.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>13</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>INSMVNGGSAESKAIFEAKA</LinearSequence>
                                        <StartingPosition>121</StartingPosition>
                                        <EndingPosition>140</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAR21088.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>32019</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <BCellId>8974</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9940</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>32019</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>2 injections of 10&lt;sup&gt;8&lt;/sup&gt; CFU at 6 wk intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <AssayComments>No significant differences in reactivity to this peptide between pooled pre- and post-challenge sera is seen.  Peptides were covalently linked to the ELISA plated via EDC / NHS immobilization chemistry.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>13</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>INSMVNGGSAESKAIFEAKA</LinearSequence>
                                        <StartingPosition>121</StartingPosition>
                                        <EndingPosition>140</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAR21088.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>32019</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>14</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>ESKAIFEAKAAASDYFADAT</LinearSequence>
                        <StartingPosition>131</StartingPosition>
                        <EndingPosition>150</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAR21088.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>32019</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 6, Pubmed entry.</LocationOfData>
                <EpitopeId>14175</EpitopeId>
                <ReferenceStartingPosition>131</ReferenceStartingPosition>
                <ReferenceEndingPosition>150</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This epitope corresponds to the 184aa N-ter region, which is conserved in all SLPs described to date. Also known as Surface array protein (SAP), member of a  family of proteins in the bacteria surface and related to its virulence.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 6</LocationOfData>
                        <BCellId>8975</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAR21088.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>32019</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Surface Layer Protein (SLP)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 immunizations, 1st in CFA then in IFA at 4 wk intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>2</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>No significant differences in reactivity to this peptide between each immune sera and pooled preimmune sera is seen.  Peptides were covalently linked to the ELISA plated via EDC / NHS immobilization chemistry.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>14</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ESKAIFEAKAAASDYFADAT</LinearSequence>
                                        <StartingPosition>131</StartingPosition>
                                        <EndingPosition>150</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAR21088.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>32019</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <BCellId>8976</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9940</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>32019</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>2 injections of 10&lt;sup&gt;8&lt;/sup&gt; CFU at 6 wk intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <AssayComments>No significant differences in reactivity to this peptide between pooled pre- and post-challenge sera is seen.  Peptides were covalently linked to the ELISA plated via EDC / NHS immobilization chemistry.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>14</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>ESKAIFEAKAAASDYFADAT</LinearSequence>
                                        <StartingPosition>131</StartingPosition>
                                        <EndingPosition>150</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAR21088.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>32019</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>15</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>AASDYFADATLGKDISGLDE</LinearSequence>
                        <StartingPosition>141</StartingPosition>
                        <EndingPosition>160</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAO64210.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>32019</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 6, Pubmed entry.</LocationOfData>
                <EpitopeId>427</EpitopeId>
                <ReferenceStartingPosition>141</ReferenceStartingPosition>
                <ReferenceEndingPosition>160</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This epitope corresponds to the 184aa N-ter region, which is conserved in all SLPs described to date. Also known as Surface array protein (SAP), member of a  family of proteins in the bacteria surface and related to its virulence.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 6</LocationOfData>
                        <BCellId>8977</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAO64210.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>32019</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Surface Layer Protein (SLP)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 immunizations, 1st in CFA then in IFA at 4 wk intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <NumberOfSubjectsTested>2</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>2</NumberOfSubjectsResponded>
                            <ResponseFrequency>100</ResponseFrequency>
                            <AssayComments>Significant differences in reactivity to this peptide among both immune sera and pooled preimmune sera is seen.  Peptides were covalently linked to the ELISA plated via EDC / NHS immobilization chemistry.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>15</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AASDYFADATLGKDISGLDE</LinearSequence>
                                        <StartingPosition>141</StartingPosition>
                                        <EndingPosition>160</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAO64210.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>32019</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <BCellId>8978</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9940</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>32019</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>2 injections of 10&lt;sup&gt;8&lt;/sup&gt; CFU at 6 wk intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <AssayComments>No significant differences in reactivity to this peptide between pooled pre- and post-challenge sera is seen.  Peptides were covalently linked to the ELISA plated via EDC / NHS immobilization chemistry.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>15</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>AASDYFADATLGKDISGLDE</LinearSequence>
                                        <StartingPosition>141</StartingPosition>
                                        <EndingPosition>160</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAO64210.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>32019</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>16</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>LGKDISGLDEGTTSKLISEI</LinearSequence>
                        <StartingPosition>151</StartingPosition>
                        <EndingPosition>170</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAO64210.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>32019</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 6, Pubmed entry.</LocationOfData>
                <EpitopeId>36175</EpitopeId>
                <ReferenceStartingPosition>151</ReferenceStartingPosition>
                <ReferenceEndingPosition>170</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This epitope corresponds to the 184aa N-ter region, which is conserved in all SLPs described to date. Also known as Surface array protein (SAP), member of a  family of proteins in the bacteria surface and related to its virulence.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 6</LocationOfData>
                        <BCellId>8979</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAO64210.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>32019</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Surface Layer Protein (SLP)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 immunizations, 1st in CFA then in IFA at 4 wk intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>2</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>No significant differences in reactivity to this peptide between each immune sera and pooled preimmune sera is seen.  Peptides were covalently linked to the ELISA plated via EDC / NHS immobilization chemistry.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>16</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LGKDISGLDEGTTSKLISEI</LinearSequence>
                                        <StartingPosition>151</StartingPosition>
                                        <EndingPosition>170</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAO64210.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>32019</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <BCellId>8980</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9940</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>32019</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>2 injections of 10&lt;sup&gt;8&lt;/sup&gt; CFU at 6 wk intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <AssayComments>No significant differences in reactivity to this peptide between pooled pre- and post-challenge sera is seen.  Peptides were covalently linked to the ELISA plated via EDC / NHS immobilization chemistry.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>16</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>LGKDISGLDEGTTSKLISEI</LinearSequence>
                                        <StartingPosition>151</StartingPosition>
                                        <EndingPosition>170</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAO64210.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>32019</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
            <Epitope>
                <EpitopeName>17</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalSequenceMolecule>
                        <ChemicalType>Peptide from protein</ChemicalType>
                        <LinearSequence>GTTSKLISEINSASDLDKVK</LinearSequence>
                        <StartingPosition>161</StartingPosition>
                        <EndingPosition>180</EndingPosition>
                        <SourceMolecule>
                            <GenBankId>AAR21088.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>32019</SourceOrganismId>
                    </FragmentOfANaturalSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Fig 6, Pubmed entry.</LocationOfData>
                <EpitopeId>22861</EpitopeId>
                <ReferenceStartingPosition>161</ReferenceStartingPosition>
                <ReferenceEndingPosition>180</ReferenceEndingPosition>
                <EpitopeEvidenceCode>Not determined</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Epitope containing region/antigenic site</EpitopeStructureDefines>
                <EpitopeComments>This epitope corresponds to the 184aa N-ter region, which is conserved in all SLPs described to date. Also known as Surface array protein (SAP), member of a  family of proteins in the bacteria surface and related to its virulence.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 6</LocationOfData>
                        <BCellId>8981</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000206</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>AAR21088.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>32019</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Surface Layer Protein (SLP)</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Adjuvant>Freund's complete</Adjuvant>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>3 immunizations, 1st in CFA then in IFA at 4 wk intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>2</NumberOfSubjectsTested>
                            <NumberOfSubjectsResponded>0</NumberOfSubjectsResponded>
                            <AssayComments>No significant differences in reactivity to this peptide between each immune sera and pooled preimmune sera is seen.  Peptides were covalently linked to the ELISA plated via EDC / NHS immobilization chemistry.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>17</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GTTSKLISEINSASDLDKVK</LinearSequence>
                                        <StartingPosition>161</StartingPosition>
                                        <EndingPosition>180</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAR21088.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>32019</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 7</LocationOfData>
                        <BCellId>8982</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>9940</OrganismId>
                                <Sex>F</Sex>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>32019</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Not determined</ImmunogenEvidenceCode>
                                <Route>Subcutaneous (s.c.)</Route>
                                <DoseSchedule>2 injections of 10&lt;sup&gt;8&lt;/sup&gt; CFU at 6 wk intervals.</DoseSchedule>
                            </FirstInVivoProcess>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Negative</QualitativeMeasurement>
                            <NumberOfSubjectsTested>6</NumberOfSubjectsTested>
                            <AssayComments>No significant differences in reactivity to this peptide between pooled pre- and post-challenge sera is seen.  Peptides were covalently linked to the ELISA plated via EDC / NHS immobilization chemistry.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Serum</AssayedAntibodySourceMaterial>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>17</AntigenReferenceName>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Epitope</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalSequenceMolecule>
                                        <ChemicalType>Peptide from protein</ChemicalType>
                                        <LinearSequence>GTTSKLISEINSASDLDKVK</LinearSequence>
                                        <StartingPosition>161</StartingPosition>
                                        <EndingPosition>180</EndingPosition>
                                        <SourceMolecule>
                                            <GenBankId>AAR21088.1</GenBankId>
                                        </SourceMolecule>
                                        <SourceOrganismId>32019</SourceOrganismId>
                                    </FragmentOfANaturalSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

